AMGN

NASDAQ · Biotechnology

Amgen Inc

S&P 500 Nasdaq 100 Dow Jones Mega-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$384.32

+16.52 (+4.49%)

As of Feb 12, 6:29 PM ET ·

Analyst Consensus

Hold

Analysts

Very High

Coverage

Buy 22 54%

Hold 16 39%

Sell 3 7%

Price Target

Analyst Price Target -50.3% upside

Low Target $141.50

Average Target $190.87

High Target $279.75

Current Price $384.32

Current
$384.32

Target
$190.87

$141.50 $190.87 avg $279.75

Scenario Analysis

Bear Case

$141.50

-63.2%

Low target

Base Case

$190.87

-50.3%

Avg target

Bull Case

$279.75

+-27.2%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$385.12

-0.2% from high

52-Week Low

$261.43

+47.0% from low

50-Day SMA

$335.30

+14.6% vs SMA

200-Day SMA

$302.96

+26.9% vs SMA

RSI (14)

79.6

Overbought

Target vs 52W High

$190.87

-50.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%